Sky View Investment Advisors, LLC Gilead Sciences, Inc. Transaction History
Sky View Investment Advisors, LLC
- $602 Million
- Q3 2024
A detailed history of Sky View Investment Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sky View Investment Advisors, LLC holds 8,482 shares of GILD stock, worth $908,252. This represents 0.12% of its overall portfolio holdings.
Number of Shares
8,482
Previous 8,047
5.41%
Holding current value
$908,252
Previous $552,000
28.8%
% of portfolio
0.12%
Previous 0.1%
Shares
13 transactions
Others Institutions Holding GILD
# of Institutions
2,101Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$12.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.4 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.68 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.47 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.2 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $134B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...